BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Week in Review: Eli Lilly and Company (LLY) Invests $100 Million in China Animal Healthcare Ltd.


4/15/2013 9:45:48 AM

by Richard Daverman, PhD

April 13, 2013 -- Eli Lilly’s animal health division, Elanco, will pay $100 million to buy a 20% stake in China Animal Healthcare Ltd.; OriGene Technologies acquired the assets of SDIX, an antibody maker, for $16 million; Tong Ren Tang plans to IPO a subsidiary, TRT Chinese Medicine, on the ChiNext exchange in Q2; the National Center for Drug Screening of China and PerkinElmer will collaborate to validate new diagnostic tests for diabetes in Asian populations; Eddingpharm will market and distribute Tykerb, a GlaxoSmithKline breast cancer drug, in China; China issued its expanded 2012 Essential Drug List along with a directive telling local governments to consider quality – not just price – when choosing drug suppliers; the US FDA asked for $4.7 million to carry out inspections of China pharmas that export to the US during fiscal year 2014; and China’s SFDA will fast-track approvals of peramivir, a flu treatment, in response to the bird flu outbreak. More details….

Stock Symbols: (NYSE: LLY) (NSDQ: SDIX) (HK: 01666) (NYSE: PKI) (NYSE: GSK)



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES